Apogee Therapeutics, Inc.
APGEDelisted Sep 3, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001974640
Apogee Therapeutics, Inc. was delisted on Sep 3, 2026; its insiders filed their last Form 4 on Sep 3, 2026; 288 institutions reported holding it in 13F filings for Q2 2026, worth $8.93B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q1 2024
Institutional positions in Apogee Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 139
- +54 vs. Q4 2023
- Shares held
- 52.9M
- +11.1M (+26.7%) vs. Q4 2023
- Total value
- $3.52B
- +$2.35B (+202.2%) vs. Q4 2023
- New holders
- 62
- 52 more added
- Sold out
- 8
- 19 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APGE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 288 | $8.93B |
| Q1 2026 | 224 | $6.64B |
| Q4 2025 | 207 | $5.27B |
| Q3 2025 | 174 | $2.37B |
| Q2 2025 | 183 | $2.51B |
| Q1 2025 | 169 | $2.30B |
| Q4 2024 | 158 | $2.62B |
| Q3 2024 | 139 | $3.29B |
| Q2 2024 | 139 | $2.13B |
| Q1 2024 | 139 | $3.52B |
| Q4 2023 | 85 | $1.16B |
| Q3 2023 | 73 | $848.7M |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Apogee Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| American Century Companies Inc | 6,474 | $430.2K | 0.00% | +6,474 | New |
| Janus Henderson Group PLC | 6,110 | $405.6K | 0.00% | −473,576−98.7% | Reduced |
| ADAR1 Capital Management, LLC | 6,000 | $398.7K | 0.11% | +6,000 | New |
| Glenmede Trust Co NA | 5,882 | $390.9K | 0.00% | +5,882 | New |
| Arizona State Retirement System | 5,735 | $381.1K | 0.00% | +5,735 | New |
| Virtu Financial LLC | 5,446 | $362.0K | 0.03% | +5,446 | New |
| Principal Financial Group Inc | 5,102 | $339.0K | 0.00% | +5,102 | New |
| Raymond James Financial Services Advisors, Inc. | 4,874 | $323.9K | 0.00% | +4,874 | New |
| Legato Capital Management LLC | 4,792 | $318.4K | 0.04% | +4,792 | New |
| Teacher Retirement System of Texas | 4,451 | $296.0K | 0.00% | +4,451 | New |
| HSBC Holdings PLC | 4,398 | $292.2K | 0.00% | +4,398 | New |
| Ameritas Investment Partners, Inc. | 4,126 | $274.2K | 0.01% | +2,172+111.2% | Added |
| Two Sigma Advisers, LP | 4,100 | $272.4K | 0.00% | +4,100 | New |
| STRS Ohio | 3,900 | $259.0K | 0.00% | −200−4.9% | Reduced |
| Virtus ETF Advisers LLC | 3,727 | $247.7K | 0.13% | −257−6.5% | Reduced |
| Balyasny Asset Management LLC | 3,561 | $236.6K | 0.00% | +3,561 | New |
| Cerity Partners LLC | 3,211 | $213.4K | 0.00% | +3,211 | New |
| Kennedy Capital Management, Inc. | 3,188 | $211.8K | 0.00% | +3,188 | New |
| E Fund Management Co., Ltd. | 3,125 | $207.7K | 0.01% | +3,125 | New |
| SG Americas Securities, LLC | 2,317 | $154.0K | 0.00% | −4,290−64.9% | Reduced |
| Qube Research & Technologies Ltd | 2,264 | $150.4K | 0.00% | +2,264 | New |
| Metropolitan Life Insurance Co | 2,185 | $145.2K | 0.01% | +1,011+86.1% | Added |
| EntryPoint Capital, LLC | 1,997 | $132.7K | 0.12% | +617+44.7% | Added |
| Royal Bank of Canada | 1,568 | $105.0K | 0.00% | −4,841−75.5% | Reduced |
| Amalgamated Bank | 1,388 | $92.0K | 0.00% | −853−38.1% | Reduced |
| Catalyst Funds Management Pty Ltd | 334 | $22.2K | 0.01% | +334 | New |
| Pacer Advisors, Inc. | 310 | $20.6K | 0.00% | +310 | New |
| Tower Research Capital LLC (TRC) | 256 | $17.0K | 0.00% | −7,570−96.7% | Reduced |
| Daiwa Securities Group Inc. | 137 | $9.00K | 0.00% | −59−30.1% | Reduced |
| nVerses Capital, LLC | 100 | $6.64K | 0.02% | +100 | New |
| Washington Trust Advisors, Inc. | 96 | $6.38K | 0.00% | 00.0% | Unchanged |
| Red Tortoise LLC | 94 | $6.25K | 0.00% | 00.0% | Unchanged |
| Bellevue Asset Management, LLC | 36 | $2.39K | 0.00% | +36 | New |
| Nisa Investment Advisors, LLC | 25 | $1.66K | 0.00% | +25 | New |
| GAMMA Investing LLC | 13 | $864 | 0.00% | +13 | New |
| Rothschild Investment LLC | 5 | $332 | 0.00% | +5 | New |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 5 | $332 | 0.00% | +5 | New |
| CWM, LLC | 1 | $0 | 0.00% | +1 | New |
| Covestor Ltd | 3 | $0 | 0.00% | +3 | New |
| Vivo Capital, LLC | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Frazier Life Sciences Management, L.P. | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Holocene Advisors, LP | 0 | $0 | 0.00% | −101,202−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −18,344−100.0% | Sold out |
| Caxton Corp | 0 | $0 | 0.00% | −7,353−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −12−100.0% | Sold out |